Organic compounds

Details for Australian Patent Application No. 2006255084 (hide)

Owner Novartis AG

Inventors Wang, Yaping; Straub, Christopher S.; Sharma, Sushil K.; Wang, Run-Ming D.; Palermo, Mark G.; Smith, Troy; Zawel, Leigh; Chen, Zhuoliang

Agent Davies Collison Cave

Pub. Number AU-A-2006255084

PCT Pub. Number WO2006/133147

Priority 60/688,639 08.06.05 US

Filing date 6 June 2006

Wipo publication date 14 December 2006

International Classifications

C07K 5/02 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

A61P 35/00 (2006.01) Antineoplastic agents

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/133147 Priority application(s): WO2006/133147

31 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006255085-Method of producing antibodies with modified fucosylation level

2006255083-Method of neutralizing a stain on a surface